Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Introduction: Myelosuppression, a challenge in cancer treatment, often results in severe complications. Prophylactic granulocyte colony-stimulating factors, particularly pegfilgrastim, mitigate chemotherapy-induced neutropenia. This narrative review evaluates the role of on-body injector (OBI) devices for pegfilgrastim administration. A comprehensive search strategy of PubMed and AI-powered intuitive search tools, complemented by authors' contributions, yielded a body of papers presenting evidence on OBI devices, their effectiveness and safety, the benefits and challenges of OBI versus pre-filled syringe administration, patient preferences for pegfilgrastim administration, and economic considerations.
Discussion: OBI devices prove effective and safe, with advantages such as reduced clinic visits and enhanced adherence. Studies highlight cost-efficiency and expanded access, emphasizing the socioeconomic context. Patient and provider preferences underscore the potential of OBI devices in cancer care, with implications for healthcare resource utilization and pharmacoeconomics.
Conclusion: The value proposition of OBI devices lies in improving patient outcomes, convenience, resource optimization, and enhancing the overall cancer care experience. As biosimilar OBIs enter the market, they may offer cost savings, further influencing their adoption and their positioning as a cost-efficient alternative in cancer care. Ongoing research and technological advancements are expected to contribute to the broader acceptance of OBI devices in cancer care delivery.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ctarc.2024.100824 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development and evaluation of a comprehensive QA phantom for image quality and geometrical accuracy in CT and CBCT for radiotherapy.
J Appl Clin Med Phys
September 2025
Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul, Republic of Korea.
Purpose: This study presents MZ CUBE, a newly developed multipurpose phantom designed to assess both image quality and geometrical accuracy in image-guided radiotherapy.
Methods: The phantom is a 16 × 16 × 16 cm cube made of acrylonitrile butadiene styrene and designed to evaluate HU constancy, HU uniformity, spatial integrity, spatial resolution, low contrast resolution, and geometrical accuracy. Two CT simulators (Big Bore RT and Discovery RT Gen3) and two cone-beam CT (CBCT) systems (XVI and OBI) were used for verification alongside commercial phantoms (ACR 464 and CatPhan 504).
Hybrid GPU Monte Carlo software toolkit for fast and accurate cone-beam CT simulation.
Med Phys
August 2025
Dana Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.
Background: With the ever-increasing dependence on cone-beam CT (CBCT) for clinical decision-making, faster and more accurate CBCT simulation tools are necessary to develop the next generation of CBCT techniques and algorithms.
Purpose: GECCO, a hybrid GPU-Monte Carlo (MC) software toolkit was built for the dual purpose of increasing both speed and accuracy in CBCT simulation. GECCO contains two applications: The GECCO application, a rapid converter of CT to CBCT, and the real-time image simulation (RTIS) application, a purely analytical approach that updates CBCT images in real-time according to acquisition technique.
Use of a deep learning neural network to generate bone suppressed images for markerless lung tumor tracking.
Med Phys
July 2025
Department of Radiation Oncology, Stritch School of Medicine, Cardinal Bernadin Cancer Center, Loyola University Chicago, Maywood, Illinois, USA.
Background: Markerless tumor tracking (MTT) is being considered for real-time motion management of lung tumors. However, bony structures in conventional x-ray images can obfuscate the tumor, increasing tracking difficulty. Bone suppression using dual energy subtraction (DES) can improve tumor visibility but requires additional hardware or software that is not currently available with commercial on-board imaging (OBI) systems.
View Article and Find Full Text PDFTesting a Liquid Crystal Visual Thermometer Device in Newborns and Young Infants.
Cureus
May 2025
Department of Pediatrics, Hennepin County Medical Center, Minneapolis, USA.
Objective Severe neonatal jaundice is a major cause of death and disability among newborns in low- and middle-income countries (LMICs). Filtered sunlight phototherapy (FSPT) is safe and effective but requires hourly temperature monitoring to detect hyperthermia/hypothermia. This need for close temperature monitoring by family members and community health extension workers is impeding FSPT scale-up in LMICs, where healthcare providers are scarce and nurseries are understaffed.
View Article and Find Full Text PDFPharmacokinetic bioequivalence of the fixed-dose combination of pertuzumab and trastuzumab administered subcutaneously using a handheld syringe or an on-body delivery system.
J Cancer Res Clin Oncol
June 2025
Product Development Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Purpose: This randomized, open-label, two-arm, parallel-group, single dose, multi-center phase I study (ClinicalTrials.gov ID, NCT05275010) investigated the comparability of the pharmacokinetics of a new formulation combining pertuzumab (P) and trastuzumab (H) in one fixed-dose combination for subcutaneous injection (FDC SC) using a proprietary on-body injector (OBI) or a handheld syringe with hypodermic needle in healthy male subjects.
Methods: Healthy male subjects were randomized 1:1 to either PH FDC SC using a handheld syringe (Arm 1) or an OBI device (Arm 2).